Followers | 401 |
Posts | 17546 |
Boards Moderated | 0 |
Alias Born | 07/14/2003 |
Tuesday, May 23, 2023 9:08:40 AM
*** Company Assessment From Accredited Analyst*** - *** No Mention by them Either!***
*** There is No Concerning Event Detected, *** - The Company For the Nine Months, Sales was USD 3.59 million compared to USD 1.05 million a year ago.
***Pass
Have shareholders been diluted over the past year?
***Shareholders Have Not Been "Meaningfully" Diluted in the past year or recently listed
***Trading at 98.5% below our estimate of its fair value
***Became Profitable this year
***SimplyWallStreet***
https://simplywall.st/stocks/us/healthcare/otc-grst/ethema-health - ***From Post #46312***
***Financial Times***
***https://markets.ft.com/data/equities/tearsheet/profile?s=GRST:PKC
***Income statement (USD)
Year on year Ethema Health Corp grew revenues 148.16% from 1.94m to 4.82m while net income improved from a loss of 1.54m to a gain of 247.88k.
***COMMITMENT***
It is fundamental to our integrity and success that we uphold the highest possible standards of ethical and professional journalism, and that we are seen to do so. The benchmark for the FT’s journalistic practices is set by our FT Editorial Code. Compliance with the code is an obligation for all FT editorial staff.
==============================================================
Recent GRST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:45:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:54:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:04:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:55:26 PM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:29:40 PM
- Form 1-A POS - • Edgar (US Regulatory) • 08/29/2023 07:21:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:37:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:43:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 04:51:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 06:56:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM